(4-traders.com) South San Francisco, CA - October 3, 2014 - Titan Pharmaceuticals, Inc. (TTNP.OB), a specialty pharmaceutical company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura™ long-term delivery technology, today announced the pricing of an underwritten public offering of...http://www.4-traders.com/TITAN-PHARMACEUTICALS-IN-4979591/news/Titan-Pharmaceuticals--October-3-2014-Titan-Pharmaceuticals-Announces-Pricing-of-Public-Offering-19172333/